Troponin I
TNI
Description
Troponin I test measures the level of troponin I, a protein in your blood that helps doctors assess heart health. It’s mainly used to detect heart attacks, myocarditis, or other cardiac issues. After taking a blood sample, your doctor checks the troponin levels—higher-than-normal results may indicate heart muscle damage or stress. This test is especially useful for people experiencing chest pain, difficulty breathing, or other heart-related symptoms. If troponin levels are elevated, your doctor may compare them with other heart markers to get a clearer picture of what’s happening. The results give doctors the details needed to make an accurate diagnosis and create a treatment plan, whether it involves immediate care, medications, or lifestyle adjustments. Regular monitoring helps track heart health, particularly for those at high risk or recovering from heart problems.
Procedure
Invasive
Sample Type
Blood – Serum
Test Category
Proteins
Procedure Category
Blood Draw
Units
Nanograms Per Milliliter
Test Groups
Cardio Risk Group: This group focuses on assessing various markers associated with cardiovascular health and risk factors, aiding in the early detection and management of cardiovascular diseases.
Optimal Range
For All Individuals:
Conventional Unit: Not Available
SI Unit: Not Available
Normal Range
For All Individuals:
Conventional Unit: < 0.03 ng/mL
SI Unit: Not Applicable
Results That Differ From The Norm (Direct and Indirect Causes)
Increased levels may indicate:
Angioplasty (Procedure to widen narrowed or obstructed arteries)
Cardiomyopathy (Disease of the heart muscle)
Coronary artery bypass grafting (Surgical procedure to improve blood flow to the heart)
Coronary artery disease (Narrowing or blockage of coronary arteries)
Heart failure (Inability of the heart to pump blood effe...
Key Reasons For Testing
Cardiac Injury Marker: Detects myocardial injury, aiding in the diagnosis of acute coronary syndromes.
Identifying High-Risk Patients: Elevated levels help identify patients at greater risk, guiding treatment decisions.
Diagnosis of Myocardial Infarction: Confirms myocardial infarction for prompt intervention and management.
Prognostic Indicator: Provides information on the severity and prognosis of cardiac events.
Rule Out Non-Cardiac Causes: Negative results help exclude cardiac origins of chest pain.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264.
[2] Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J. Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care. Clin Chem. 2017;63(1):73-81.
[3] Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes. Circulation. 2014;130(25).
[4] Chapman AR, Lee KK, McAllister DA, et al. Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome. JAMA. 2017;318(19):1913-1924.
[5] Sandoval Y, Smith SW, Sexter A, et al. Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High-Sensitivity Cardiac Troponin I. Am J Med. 2017;130(12):1431-1439.e4.
[6] Jaffe AS, Morrow DA. Troponin Testing: Analytical and Clinical Considerations. Cardiol Clin. 2014;32(3):295-305.
[7] Newby LK, Jesse RL, Babb JD, et al. ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations. J Am Coll Cardiol. 2012;60(23):2427-2463.
[8] Sandoval Y, Jaffe AS. High-Sensitivity Cardiac Troponin Assays: A Review of Analytical and Clinical Characteristics. J Clin Cardiol. 2019;32(5):253-262.
[9] Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation. Eur Heart J. 2016;37(3):267-315.
[10] Wu AH, Apple FS, Gibler WB, et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem. 1999;45(7):1104-1121.
[11] Mills NL, Churchhouse AM, Lee KK, et al. Implementation of High-Sensitivity Cardiac Troponin Testing in Acute Coronary Syndromes: Real-World Experience. Circulation. 2011;123(20):2400-2410.
[12] Peacock WF, Baumann BM, Bruton D, et al. The Effectiveness of High-Sensitivity Troponin in Diagnosing Acute Myocardial Infarction. Am J Emerg Med. 2021;39:225-231.
[13] Twerenbold R, Boeddinghaus J, Nestelberger T, et al. Clinical Use of High-Sensitivity Cardiac Troponin in Patients with Suspected Myocardial Infarction. J Am Coll Cardiol. 2017;70(8):996-1012.
[14] Cullen L, Parsonage WA, Greenslade JH, et al. Comparison of Early Biomarker Strategies with the Heart Foundation Risk Stratification for Acute Coronary Syndromes in the Emergency Department. Heart Lung Circ. 2013;22(2):108-118.
[15] Sandoval Y, Smith SW, Sexter A, et al. Clinical Implications of Troponin Testing. Am Heart J. 2016;172(1):12-19.